ontazolast has been researched along with leukotriene b4 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, J; Borgeat, P; Dinallo, RM; Farina, PR; Graham, AG; Hansen, G; Hoffman, AF; Miao, CK; Nadeau, M; Watrous, JM | 1 |
| Ficorilli, JV; Fogal, SE; Hauss, DJ; Jayaraj, AA; Keirns, JJ; Price, CA; Roy, T | 1 |
2 other study(ies) available for ontazolast and leukotriene b4
| Article | Year |
|---|---|
BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
Topics: Arachidonic Acid; Benzoxazoles; Calcimycin; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor | 1994 |
Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor.
Topics: Administration, Oral; Analysis of Variance; Animals; Area Under Curve; Benzoxazoles; Biological Availability; Chylomicrons; Drug Carriers; Emulsions; Excipients; Glycerides; Half-Life; Injections, Intravenous; Intestinal Absorption; Leukotriene B4; Lymphatic System; Male; Rats; Rats, Inbred Strains; Solubility; Soybean Oil; Suspensions; Triglycerides | 1998 |